Physician profile
Patrick Lawrence Mallory
NPI 1164446514
$1,817.11
in general payments reported to CMS, 2019-2025
24 companies · $308 in 2025
The $308 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $346 · 2020: $313 · 2021: $388 · 2022: $89.94 · 2023: $199 · 2024: $173 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $497.54 | 2019-2024 | Xifaxan, Trulance |
| Abbvie INC. | $303.18 | 2021-2025 | |
| Amgen INC. | $124.25 | 2019-2021 | |
| Pfizer INC. | $106.59 | 2019-2025 | |
| Allergan, INC. | $106.29 | 2019-2021 | |
| Corium, LLC | $103.83 | 2022-2024 | Azstarys |
| Lilly USA, LLC | $78.93 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $73.45 | 2024-2025 | |
| Jazz Pharmaceuticals INC. | $52.08 | 2020-2021 | |
| Cleerly, INC. | $51.17 | 2024-2025 | Cleerly Ischemia, Cleerly Labs |
| Exact Sciences Corporation | $40.01 | 2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $32.95 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $30.52 | 2020-2021 | |
| Axsome Therapeutics, INC. | $29.30 | 2025 | Sunosi |
| Novo Nordisk INC | $28.03 | 2025 | Wegovy |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $26.62 | 2023 | Veozah |
| Eisai INC. | $21.00 | 2020 | |
| Idorsia Pharmaceuticals US INC | $20.73 | 2023 | Quviviq |
| Therapeuticsmd, INC. | $18.21 | 2019 | |
| Alfasigma USA, INC. | $15.83 | 2020 | |
| Heartflow, INC. | $15.73 | 2025 | |
| Galderma Laboratories, L.P. | $15.30 | 2020 | |
| Acella Pharmaceuticals, LLC | $14.46 | 2025 | NP Thyroid 60 |
| Antares Pharma, INC. | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mallory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.